drugset / Trial / NCT00706615

Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer

NCT00706615 ↗

Non-randomizedOpen-labelTreatment

Summary

RATIONALE: Vaccines may help the body build an effective immune response to kill tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of vaccine therapy in treating women with previously treated metastatic breast cancer.

Timeline

Start
2008-07
Primary completion
2009-04
Completion
—

Outcome

Outcome not reported

Stopped (Enrollment): “no accrual”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ad-sig-hMUC-1/ecdCD40L Vaccine — Subcutaneous

Indications